The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection

To determine the validity of sequence symmetry analysis (SSA) method to detect adverse drug reactions from an administrative claims database.

[1]  H. Petri,et al.  Prescription sequence analysis: a new and fast method for assessing certain adverse reactions of prescription drugs in large populations. , 1988, Statistics in medicine.

[2]  Brämer Gr.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[3]  A. Dyer,et al.  Dietary Beta‐Carotene, Vitamin C, and Risk of Prostate Cancer , 1996, Epidemiology.

[4]  J. Hallas.  Evidence of Depression Provoked by Cardiovascular Medication: A Prescription Sequence Symmetry Analysis , 1996, Epidemiology.

[5]  G Lindberg,et al.  Cholesterol‐lowering drugs and antidepressants—A study of prescription symmetry , 1998, Pharmacoepidemiology and drug safety.

[6]  M. Lindquist,et al.  A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database , 2000, Drug safety.

[7]  J. Hallas,et al.  Drug‐induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions , 2000, Alimentary pharmacology & therapeutics.

[8]  Hugh P. Levaux,et al.  Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. , 2003, Journal of the American Academy of Dermatology.

[9]  Giovanni Corrao,et al.  Generating signals of drug‐adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials , 2005, Pharmacoepidemiology and drug safety.

[10]  Jesper Hallas,et al.  Statins and nonsteroidal anti‐inflammatory drugs—an analysis of prescription symmetry , 2006, Pharmacoepidemiology and drug safety.

[11]  Isao Yoshimura,et al.  Criteria Revision and Performance Comparison of Three Methods of Signal Detection Applied to the Spontaneous Reporting Database of a Pharmaceutical Manufacturer , 2007, Drug safety.

[12]  A L Gould,et al.  An Evaluation of Computer‐Aided Disproportionality Analysis for Post‐Marketing Signal Detection , 2007, Clinical pharmacology and therapeutics.

[13]  P. Vichyanond,et al.  The utility of the World Health Organization-The Uppsala Monitoring Centre (WHO-UMC) system for the assessment of adverse drug reactions in hospitalized children. , 2008, Asian Pacific journal of allergy and immunology.

[14]  Jesper Hallas,et al.  Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis , 2009, Pharmacoepidemiology and drug safety.

[15]  S. Vegter,et al.  Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced cough. , 2010, British journal of clinical pharmacology.

[16]  Nicole Pratt,et al.  Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? , 2010, Pharmacoepidemiology and drug safety.

[17]  N. Pratt,et al.  Stroke risk and NSAIDs: an Australian population‐based study , 2011, The Medical journal of Australia.

[18]  Ju-Young Kim,et al.  Comparison and validation of data‐mining indices for signal detection: using the Korean national health insurance claims database , 2011, Pharmacoepidemiology and drug safety.

[19]  Karim M Khan,et al.  Nocturnal leg cramps and prescription use that precedes them: a sequence symmetry analysis. , 2012, Archives of internal medicine.